Inhibidores de IRE-1A

Inhibidores de IRE-1A

Compuesto o sal farmacéuticamente aceptable del mismo, en el que el compuesto inhibe directamente la actividad de IRE-1α in vitro y se selecciona entre: **(Tabla)** Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WADE, Warren Stanfield, ZENG, Qingping, ZUBOVICS, Zoltan, YANG, Yun, PATTERSON, John Bruce, WU, Zhipeng, TORO, Andras
Format: Patent
Sprache:spa
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compuesto o sal farmacéuticamente aceptable del mismo, en el que el compuesto inhibe directamente la actividad de IRE-1α in vitro y se selecciona entre: **(Tabla)** Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.